Drug Shortage Report for RIFADIN

Last updated on 2018-02-02 History
Report ID 35644
Drug Identification Number 02091887
Brand name RIFADIN
Common or Proper name Rifadin 150mg
Company Name SANOFI-AVENTIS CANADA INC
Market Status DORMANT
Active Ingredient(s) RIFAMPIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100's
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-01-05
Estimated end date 2018-01-30
Actual end date 2018-01-31
Shortage status Resolved
Updated date 2018-02-02
Company comments Delay in supply
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-01-10 English Compare
v2 2018-01-10 French Compare
v3 2018-02-02 English Compare
v4 2018-02-02 French Compare